Herbert Gartner

CEO & Co-Founder eQventure

📍 Styria, Austria🔄 Updated September 2026💼 29 investments📅 14 years investing🗓 Last invested Jul 2026
Operator-angel🌍 Austria20+ investmentsInvested this quarter
29
Total investments
13
Early stage
6
Mid stage
2
Late stage
14y
Years active

Portfolio

28 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Senior Investor
Jul 2026
Ageing is natural but not inevitable. Some cells never age. Imagine if we could decode their rejuvenation programme. Imagine if we could prevent the diseases caused by ageing cells. Imagine a future where health is our default state
Senior Investor
Dec 2025
We are dedicated to make a change in womens health by offering scientific information and effective solutions. Our team, consisting of passionate women deeply invested in medical research, is devoted to the development of an accessible and cost-effective diagnostic testing method for Endometriosis. Our objective is to create a solution that is swift, user-friendly, and empowering, enabling women to take charge of their own health. By placing womens requirements at the forefront, we endeavor to deliver medical solutions that are precisely tailored to their distinct medical needs.
Senior Investor
Oct 2025
2nd Cycle entwickelt eine vollautomatische Hochdurchsatz-Upcycling-Anlage die es ermöglicht gebrauchte PV-Module kosteneffizient in einen aus ökologisch, ökonomisch und aus kreislaufwirtschaftlicher Sicht sinnvollen zweiten Lebenszyklus zu bringen.
Senior Investor
May 2025
Respory entschlüsselt das gesamte Kundenverhalten in all deinen Stores, damit du Produktperformance, Marketingmaßnahmen und Storedesign regalmetergenau optimieren kannst.
Senior Investor
Mar 2025
At aTENSION.life, we develop and market innovative and precise diagnostic solutions that enable early and accurate diagnosis as well as targeted - and even personalized - treatment for people with hypertension. Our proprietary ALDO+ technology platform is based on state-of-the-art mass spectrometry and analyzes the Renin-Angiotensin-Aldosterone System (RAAS) with unparalleled precision from a single blood sample. This allows physicians to accurately identify the causes of treatment-resistant hypertension, without the need for trial-and-error approaches. The first product from this platform, ALDO+PA, is a CE-IVD-certified blood test for the diagnosis of Primary Aldosteronism (PA), one of the most common yet often overlooked causes of treatment-resistant hypertension. ALDO+PA delivers reliable results without requiring patients to stop their current medication and is available in Austria through our partnership with labors.at. With our scalable Prep’n’Ship™ model, we make mass spectrometry-based precision diagnostics accessible to any laboratory - regardless of existing infrastructure. We collaborate with physicians, laboratories, and healthcare institutions to set new standards in hypertension diagnostics and sustainably improve cardiovascular care.
Senior Investor
Nov 2024
Our non-contact measuring technology provides essential insights by thoroughly analyzing the rolling process—helping you boost efficiency, ensure precision, and uphold the highest standards at every stage of production.
Senior Investor
Dec 2022
Dayholi is the sustainable solution to experience the world from your home. Synchronously. Interactively. Anytime. Around the world. VR experiences on the next level. 360 degree live streams in brilliant 8K quality shown in VR glasses. Unique dayholi technology adds scents and wind to your personal journey with the dayholi experience room.
Senior Investor
Jul 2022
Raise the value of your machines through your digital customer platform and smart services. Autonoma helps industrial machinery- and plant building manufacturers to fully digitalize their service portfolio. With our white labelled platform, they can sell their customers a branded interface with their design to deepen their customer relationship and engagement. Customers can simulate data of machines and digital services first, to test them with customers directly. Once they create a benefit, they can invest into connecting their machines to collect and visualize all data easily, and build smart services on top of them, such as the predictive maintenance and a digital representation of their machines. As a result, customers can generate service revenues with new and retrofitted machines within weeks.
Senior Investor
May 2022
NXRT makes the invisible visible - with Mixed Reality experiences that showcase products interactively, dynamically, and with lifelike precision. For OEMs, importers, and dealer organizations looking to elevate their marketing, sales, and training processes: We deliver real impact - intuitive, fast, and with a tangible human touch.
Senior Investor
May 2022
NXRT entwickelt virtuelle XR Simulationslösungen für professionelles Training, Schulungen & Produktentwicklung im Eisenbahnwesen. Durch die hochtechnische Spezialisierung ist NXRT Teil von Expert:innengruppen, die sich dem Thema der Unfallvermeidung sowie der Mobilität der Zukunft annehmen.​ NXRT ist Kooperationspartner der Rhomberg Sersa Rail Group im Bereich „Digitalisierung und Training“.
Senior Investor
Dec 2021
Online and in one of our shops in Germany and Austria we offer loans in exchange for valuable items which we keep as a security for the duration of your loan.
Senior Investor
Jun 2021
Founded by Peter Karacsonyi in 2013, Kape is a skateboard manufacturer based in Linz, Austria. We make long-lasting skateboards. With these boards, our community of creatives and athletes create amazing things. Since our foundation, we've released multiple series which were loved by thousands of individuals across the globe. Skateboarding isn't easy. It takes time, dedicaton, and an incredibly high level of tolerance for pain and frustration. We feel the same way about making skateboards. The driving force behind Kape is our passion for skateboarding, the hardware behind it, and the community we make it for. We are always looking for talented skaters of all styles and backgrounds to join the Kape skate team. We're especially interested if you love spending every waking minute of your life doing what you love, exploring the world with your skateboard, and have a passion for leaving a positive mark on the planet and its people in the process.
Senior Investor
Apr 2021
Innovative food supplement for weight loss and reduction of the risks associated with overweight
Senior Investor
Feb 2020
Seven Bel is an Austrian manufacturer of innovative acoustic cameras for sound visualization. Unlike conventional camera manufacturers, we do not rely on beamforming technology but use our own patented algorithm which enables us to perfectly spatially resolve sound sources in the frequency band from 125 Hz to 45 KHz. Areas of application for our lead product the Sound Scanner are the areas of Noise, Vibration and Harshness (NVH), energy, machinery and building acoustics.
Senior Investor
Nov 2019
ParityQC is the world’s only quantum architecture company. It was founded in January 2020 by Wolfgang Lechner and Magdalena Hauser, as a spin-off from the University of Innsbruck. We develop blueprints and an operating system for highly scalable quantum computers, with applications ranging from solving optimization problems on NISQ devices to general-purpose, error-corrected quantum computing. The ParityQC Architecture provides unique advantages for all currently available hardware platforms and for both methods (digital and analog). We collaborate with quantum hardware developers worldwide, to jointly build highly scalable quantum computers. We are also part of several joint projects in Europe aimed at the advancement of quantum computing.
Show all 28 investments ↓
Experience · 32 entries
All (32)
Investments (29)
Founder (3)
Board (1)
2026
Senior Investor
Jul 2026
Ageing is natural but not inevitable. Some cells never age. Imagine if we could decode their rejuvenation programme. Imagine if we could prevent the diseases caused by ageing cells. Imagine a future where health is our default state
2025
Senior Investor
Dec 2025
We are dedicated to make a change in womens health by offering scientific information and effective solutions. Our team, consisting of passionate women deeply invested in medical research, is devoted to the development of an accessible and cost-effective diagnostic testing method for Endometriosis. Our objective is to create a solution that is swift, user-friendly, and empowering, enabling women to take charge of their own health. By placing womens requirements at the forefront, we endeavor to deliver medical solutions that are precisely tailored to their distinct medical needs.
Senior Investor
Oct 2025
2nd Cycle entwickelt eine vollautomatische Hochdurchsatz-Upcycling-Anlage die es ermöglicht gebrauchte PV-Module kosteneffizient in einen aus ökologisch, ökonomisch und aus kreislaufwirtschaftlicher Sicht sinnvollen zweiten Lebenszyklus zu bringen.
Senior Investor
May 2025
Respory entschlüsselt das gesamte Kundenverhalten in all deinen Stores, damit du Produktperformance, Marketingmaßnahmen und Storedesign regalmetergenau optimieren kannst.
Senior Investor
Mar 2025
At aTENSION.life, we develop and market innovative and precise diagnostic solutions that enable early and accurate diagnosis as well as targeted - and even personalized - treatment for people with hypertension. Our proprietary ALDO+ technology platform is based on state-of-the-art mass spectrometry and analyzes the Renin-Angiotensin-Aldosterone System (RAAS) with unparalleled precision from a single blood sample. This allows physicians to accurately identify the causes of treatment-resistant hypertension, without the need for trial-and-error approaches. The first product from this platform, ALDO+PA, is a CE-IVD-certified blood test for the diagnosis of Primary Aldosteronism (PA), one of the most common yet often overlooked causes of treatment-resistant hypertension. ALDO+PA delivers reliable results without requiring patients to stop their current medication and is available in Austria through our partnership with labors.at. With our scalable Prep’n’Ship™ model, we make mass spectrometry-based precision diagnostics accessible to any laboratory - regardless of existing infrastructure. We collaborate with physicians, laboratories, and healthcare institutions to set new standards in hypertension diagnostics and sustainably improve cardiovascular care.
Show all 32 entries ↓
Investment activity
2012–2026 · 29 investments
201222015320162201712018220195202012021320224202412025420261
Recent (last 2 years)Earlier